Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bios Health Group Launches Life Science Entity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Bios Health Group Launches Life Science Entity

To provide end-to-end services for life science companies and investors.

By: Anthony Vecchione

Bios Health Group has entered into the life science market as a strategic partner providing services for life science companies and investors. The company will offer strategies to attract funding, optimize clinical development and create commercial strategies. Bios Health Group also serves as a venture partner providing investor preparation for biotech companies seeking investment funding and access to Venture funds through its investor networks.

Bios Health’s four strategic solutions include:

• BioInvest offers life science companies guidance on investment preparation including business plans, investor attractive investment pitches and access to investor networks. 
• Innovate Bio focuses on clinical development optimization, prioritizing R&D indications, and pipelines to help maximize value leveraging innovations, strategic and patient-centric approaches to optimize and accelerate clinical development.
• CRO Select provides services to help Biotech companies save time and money as they make the crucial decision of selecting the right fit Clinical Research Organization.
• LaunchMax offers commercial strategy development and execution to help maximize success. In addition, the BIOS Innovation Circle brings together strategic experts to provide tailored solutions.

Bios Health Group CEO Zizi Uzezi Imatorbhebhe, said, “We are thrilled to bring this comprehensive suite of end-to-end solutions to Biotech and Life Science companies. Our strategic approach involves engagement with Venture Capitalists and Investors, effectively addressing the funding gap that often impedes early-stage Biotech companies from accessing critical financial resources required to realize their innovative concepts. Additionally, we provide established companies with proven commercial strategies to launch new products and expand their market presence”.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics